DUBLIN, Ohio, Dec. 17, 2010 /PRNewswire-FirstCall/ — Cardinal
Health today announced that the Federal Trade Commission has
granted early termination of the waiting period under the
Hart-Scott-Rodino Antitrust Improvements Act of 1976 for its
proposed acquisition of Kinray, Inc., a leading pharmaceutical
distributor serving the New York metropolitan area. Cardinal Health
now anticipates closing the Kinray transaction shortly.
About Cardinal Health
Headquartered in Dublin, Ohio, Cardinal Health, Inc. (NYSE:
CAH) is a $99 billion health care
services company that improves the cost-effectiveness of health
care. As the business behind health care, Cardinal Health helps pharmacies, hospitals, ambulatory surgery centers
and physician
offices focus on patient care while reducing costs, improving
efficiency and quality, and increasing profitability. Cardinal
Health is an essential link in the health care supply chain,
providing
pharmaceuticals and medical
products to more than 60,000 locations each day. The company is
also a leading manufacturer of medical and surgical products,
including
gloves,
surgical apparel and fluid management
products. In addition, the company supports the growing diagnostic
industry by supplying medical products to
SOURCE